22 May 2013
Keywords: Sanofi, Multaq, CHMP, EMA, Restrictions, Atrial fibrillation
Article | 23 September 2011
There was mixed news for French drug major Sanofi (Euronext: SAN) yesterday, when the European Medicines Agency's Committee for Medicinal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 September 2011
22 September 2011
21 May 2013
© 2013 thepharmaletter.com